Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders
Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of mental and physical symptoms including anxiety, co...
| Authors: | ; ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Published: |
2019
|
| In: |
Campbell Systematic Reviews
Year: 2019, Volume: 15, Issue: 1/2, Pages: 1-19 |
| Online Access: |
Volltext (kostenfrei) |
| Journals Online & Print: | Drawer...
|
| Check availability: | HBZ Gateway |
| Keywords: |
MARC
| LEADER | 00000naa a2200000 4500 | ||
|---|---|---|---|
| 001 | 1789595290 | ||
| 003 | DE-627 | ||
| 005 | 20220215110320.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220215s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cl2.1026 |2 doi | |
| 035 | |a (DE-627)1789595290 | ||
| 035 | |a (DE-599)KXP1789595290 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Harada, Takayuki |d 1964- |e VerfasserIn |0 (DE-588)1103694227 |0 (DE-627)861484312 |0 (DE-576)470735309 |4 aut | |
| 109 | |a Harada, Takayuki 1964- | ||
| 245 | 1 | 0 | |a Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders |c Takayuki Harada, Hiroshi Tsutomi, Rintaro Mori, David B. Wilson |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of mental and physical symptoms including anxiety, confusion, insomnia, mood disturbances, cognitive impairments, paranoia, hallucinations and delusion | ||
| 650 | 0 | 7 | |0 (DE-588)4122043-2 |0 (DE-627)105765236 |0 (DE-576)20954824X |a Amphetamine |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4114607-4 |0 (DE-627)104346760 |0 (DE-576)209486023 |a Missbrauch |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4059798-2 |0 (DE-627)106142216 |0 (DE-576)209132310 |a Therapie |2 gnd |
| 700 | 1 | |a Tsutomi, Hiroshi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mori, Rintaro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wilson, David B. |d 1961- |e VerfasserIn |0 (DE-588)139137904 |0 (DE-627)608609994 |0 (DE-576)31041136X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a Campbell Collaboration |t Campbell Systematic Reviews |d Oslo : [Verlag nicht ermittelbar], 2004 |g 15(2019), 1/2, Artikel-ID e1026, Seite 1-19 |h Online-Ressource |w (DE-627)781568064 |w (DE-600)2762761-5 |w (DE-576)403258073 |x 1891-1803 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2019 |g number:1/2 |g elocationid:e1026 |g pages:1-19 |
| 856 | |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cl2.1026 |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [oa journal (via doaj)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1002/cl2.1026 |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4059859648 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1789595290 | ||
| LOK | |0 005 20220215110320 | ||
| LOK | |0 008 220215||||||||||||||||ger||||||| | ||
| LOK | |0 040 |a DE-21 |c DE-627 |d DE-21 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-21 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a krim | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-krimdoka001.raw | ||